ARTICLE | Company News
Oncomatrix sales and marketing update
March 11, 2013 7:00 AM UTC
Oncomatrix launched DMTXinvaScan immunohistochemistry kit worldwide to diagnose and prognose the invasiveness of tumors. The DMTXinvaScan uses a mAb developed by Oncomatrix to detect collagen type X...